IMMIX BIOPHARMA, INC. (IMMX) Capital expenditures 2021–2025
IMMIX BIOPHARMA, INC. (IMMX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$732,925FY2025 · since FY2021: $802 → $732,925
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $732,925 | -37.8% |
| FY2024 | $1.2M | +2160.9% |
| FY2023 | $52,089 | — |
| FY2021 | $802 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice